Health & Biotech
Food & Agriculture
Economic recovery post-COVID, the five sectors that will lead the charge
Health & Biotech
Suda shares triple after TGA approves first mouth spray product
Health & Biotech
VIP Gloves leap 200pc in July as Malaysian manufacturing market stays red hot
Health & Biotech
Dimerix shares climb 40pc on FSGS drug trial success
Health & Biotech
Experts: How to position for the next wave in cannabis
Health & Biotech
These are the life sciences small caps almost unscathed by COVID-19
Health & Biotech
Opyl is eyeing a 30pc revenue hike in 2021
Health & Biotech
Respiri eyes maiden 2021 revenue of $6-8m
Health & Biotech
Positive results from MGC Pharma’s natural supplement study
Health & Biotech
Factor Therapeutics may finally have found its future — in veterinary imaging
Health & Biotech
Dimerix’s choice: do they partner or go it alone?
Health & Biotech
Australia’s cannabis sector is finally maturing
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.